Literature DB >> 2783996

The treatment of postoperative endophthalmitis. Results of differing approaches to treatment.

G A Stern1, H M Engel, W T Driebe.   

Abstract

The authors treated 26 patients with postoperative endophthalmitis over a 4-year period, between 1983 and 1986. Nineteen patients were culture-positive and seven were culture-negative. All patients received intravitreal antibiotics as part of their treatment regimen. Culture-negative patients generally responded well to a single intravitreal antibiotic injection. Five of seven (71.4%) culture-positive patients who were treated with a single intravitreal antibiotic injection and no vitrectomy suffered either a recurrence of their infection or did not respond to treatment. Four of five patients who received a vitrectomy in addition to a single intravitreal antibiotic injection were cured of their infections; the one patient who received repeated intravitreal antibiotic injections alone and all six patients who received repeated intravitreal antibiotic injections in combination with vitrectomy were cured of their infections. Although the intravitreal injection of antibiotics provides an extremely high initial level of antibiotics inside the eye, a single intravitreal antibiotic injection may only partially treat bacterial endophthalmitis. In culture-negative cases, a single intravitreal injection of antibiotics appears to be sufficient treatment. In culture-positive cases, a higher cure rate is achieved with an aggressive approach which includes the use of repeated intravitreal antibiotic injections and/or vitrectomy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783996     DOI: 10.1016/s0161-6420(89)32938-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

1.  Diagnosis and therapy of bacterial endophthalmitis, and serum levels of inflammation markers.

Authors:  V Huber-Spitzy; E Arocker-Mettinger; K Herkner; M Schiffbänker; L Georgiew; F J Steinkogler; G Grabner
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

2.  Vitreous replacement by gas as a therapeutic modality in bacterial endophthalmitis.

Authors:  A M Mansour; E Ferguson; H Lucia; M Rajashekhar; H Li; T Margo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Endophthalmitis: potential benefits of repeated intravitreal injections of antibiotics.

Authors:  M Hui; W H Lam; W H Ho; C Y Chan
Journal:  J Clin Microbiol       Date:  2008-04       Impact factor: 5.948

Review 4.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

5.  A comparison of implant extrusion rates and postoperative pain after evisceration with immediate or delayed implants and after enucleation with implants.

Authors:  Don Liu
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 6.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

7.  Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis.

Authors:  N Okhravi; H M Towler; P Hykin; M Matheson; S Lightman
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

8.  Effects of norfloxacin on the retina in rabbits.

Authors:  K Mochizuki; T Higashide; M Torisaki; Y Yamashita; M Komatsu; T Tanahashi; S Ohkubo; M Ogata; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-03       Impact factor: 3.117

Review 9.  Aggressive management of an epidemic of chronic pseudophakic endophthalmitis: results and literature survey.

Authors:  N K Rogers; P D Fox; B A Noble; K Kerr; T Inglis
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

Review 10.  Post-cataract surgery endophthalmitis: Brief literature review.

Authors:  Hesam Hashemian; Reza Mirshahi; Mehdi Khodaparast; Mahmoud Jabbarvand
Journal:  J Curr Ophthalmol       Date:  2016-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.